Stuart A. Arbuckle - Feb 12, 2025 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 12, 2025
Transactions value $
$0
Form type
4
Date filed
2/14/2025, 04:06 PM
Previous filing
Feb 12, 2025
Next filing
Feb 19, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Award $0 +7.9K +11.36% $0.00 77.4K Feb 12, 2025 Direct F1
holding VRTX Common Stock 140 Feb 12, 2025 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award that vests in installments beginning on 02/24/2026.